Edward Guilmette

1.1k total citations
15 papers, 859 citations indexed

About

Edward Guilmette is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Edward Guilmette has authored 15 papers receiving a total of 859 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Genetics and 4 papers in Immunology. Recurrent topics in Edward Guilmette's work include Complement system in diseases (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Virus-based gene therapy research (2 papers). Edward Guilmette is often cited by papers focused on Complement system in diseases (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Virus-based gene therapy research (2 papers). Edward Guilmette collaborates with scholars based in United States, Switzerland and Italy. Edward Guilmette's co-authors include William L. Fodor, Scott A. Rollins, E Setter, Stephen P. Squinto, Narin Osman, Ian F. C. McKenzie, Mauro S. Sandrin, Shlomo Cohney, S P Squinto and Joshua C. Judkins and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nature Medicine.

In The Last Decade

Edward Guilmette

15 papers receiving 839 citations

Peers

Countries citing papers authored by Edward Guilmette

Since Specialization

Citations

This map shows the geographic impact of Edward Guilmette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Guilmette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Guilmette more than expected).

Fields of papers citing papers by Edward Guilmette

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Guilmette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Guilmette. The network helps show where Edward Guilmette may publish in the future.

Co-authorship network of co-authors of Edward Guilmette

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Guilmette. A scholar is included among the top collaborators of Edward Guilmette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Guilmette. Edward Guilmette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Discovery of Small-Molecule CD33 Pre-mRNA Splicing Modulators 2022 ·ACS Medicinal Chemistry Letters ·Thomas A. Chappie, (unknown), Claude Ambroise, Markus Boehm, (unknown), Michael Green, Edward Guilmette, Claire M. Steppan, (unknown), Liuqing Wei, Simon Xi, Samuel A. Hasson	10
2	Development of a one-step RT-ddPCR method to determine the expression and potency of AAV vectors 2021 ·Molecular Therapy — Methods & Clinical Development ·(unknown), (unknown), (unknown), Edward Guilmette, Patrick Trapa, Shih‐Ching Lo, Shen Shen	7
3	The Parkinson’s disease-associated gene ITPKB protects against α-synuclein aggregation by regulating ER-to-mitochondria calcium release 2020 ·Proceedings of the National Academy of Sciences ·Daniel J. Apicco, Evgeny Shlevkov, Catherine L. Nezich, David Tran, Edward Guilmette, Justin W. Nicholatos, Collin M. Bantle, Yi Chen, Kelly E. Glajch, Neeta A. Abraham, Lan Dang, (unknown), Ellen Tsai, Khanh‐Dung H. Nguyen, (unknown), Yuting Liu, Andreas Weihofen, Jessica A. Hurt, Heiko Runz, Warren D. Hirst	44
4	Hyperactivity and Hypermotivation Associated With Increased Striatal mGluR1 Signaling in a Shank2 Rat Model of Autism 2018 ·Frontiers in Molecular Neuroscience ·Meera E. Modi, Julie M. Brooks, Edward Guilmette, Mercedes Beyna, Radka Graf, Dominik Reim, Michael J. Schmeißer, Tobias M. Boeckers, Patricio O’Donnell, Derek L. Buhl	28
5	Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor 2018 ·Nature Communications ·David Gray, John Allen, Scot Mente, Rebecca E. O’Connor, George J. DeMarco, Ivan Efremov, Patrick L. Tierney, Dmitri Volfson, Jennifer E. Davoren, Edward Guilmette, (unknown), Rouba Kozak, Michael Ehlers	75
6	Inhibition of monoacylglycerol lipase terminates diazepam‐resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet 2017 ·Epilepsia ·Gaetano Terrone, Alberto Pauletti, Alessia Salamone, Massimo Rizzi, Bianca R. Villa, Luca Porcu, (unknown), Edward Guilmette, Christopher R. Butler, Justin R. Piro, Tarek A. Samad, Annamaria Vezzani	42
7	Dopamine D1 receptor-agonist interactions: A mutagenesis and homology modeling study 2015 ·Bioorganic & Medicinal Chemistry Letters ·Scot Mente, Edward Guilmette, (unknown), David Gray	8
8	Systematic Evaluation of Bioorthogonal Reactions in Live Cells with Clickable HaloTag Ligands: Implications for Intracellular Imaging 2015 ·Journal of the American Chemical Society ·Heather E. Murrey, Joshua C. Judkins, Christopher W. am Ende, T. Eric Ballard, Yinzhi Fang, Keith Riccardi, Li Di, Edward Guilmette, Joel Schwartz, Joseph M. Fox, Douglas S. Johnson	153
9	Transcriptomic analysis of genetically defined autism candidate genes reveals common mechanisms of action 2013 ·Molecular Autism ·Thomas A. Lanz, Edward Guilmette, Mark Gosink, (unknown), Lawrence W. Fitzgerald, Diane Stephenson, Mathew T. Pletcher	43
10	EXPRESSION OF HUMAN CD59 IN TRANSGENIC PIG ORGANS ENHANCES ORGAN SURVIVAL IN AN EX VIVO XENOGENEIC PERFUSION MODEL1,2 1996 ·Transplantation ·Timothy J. Kroshus, R. Morton Bolman, Agustin P. Dalmasso, Scott A. Rollins, Edward Guilmette, Barry L. Williams, Stephen P. Squinto, William L. Fodor	70
11	Primate terminal complement inhibitor homologues of human CD59 1995 ·Immunogenetics ·William L. Fodor, Scott A. Rollins, (unknown), Willis V. Burton, Edward Guilmette, Russell P. Rother, George B. Zavoico, Stephen P. Squinto	13
12	Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis 1995 ·Nature Medicine ·Mauro S. Sandrin, William L. Fodor, (unknown), Narin Osman, Shlomo Cohney, Scott A. Rollins, Edward Guilmette, E Setter, Stephen P. Squinto, Ian F. C. McKenzie	249
13	A novel bifunctional chimeric complement inhibitor that regulates C3 convertase and formation of the membrane attack complex 1995 ·The Journal of Immunology ·William L. Fodor, (unknown), Edward Guilmette, E Setter, S P Squinto	21
14	The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity 1995 ·Journal of Virology ·William L. Fodor, Scott A. Rollins, (unknown), Russell P. Rother, Edward Guilmette, Willis V. Burton, Jens Albrecht, Bernhard Fleckenstein, S P Squinto	68
15	A novel bifunctional chimeric complement inhibitor that regulates C3 convertase and formation of the membrane attack complex. 1995 ·PubMed ·William L. Fodor, Scott A. Rollins, Edward Guilmette, E Setter, S P Squinto	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact